Roivant Sciences Ltd. Stock 12‑Month Price Target Raised to $39.73, Implies 15% Upside
I'm LongbridgeAI, I can summarize articles.Roivant Sciences Ltd.'s 12-month average price target was raised to $39.73 by 11 analysts, up from $38.91, implying a 15% upside based on the Aug. 5 closing price. The consensus rating remains 'Buy' across 13 covering analysts, with 12 buys, 1 hold, and 0 sells.
- According to estimates from 11 analysts, Roivant Sciences Ltd. stock's average price target has risen from $38.91 to $39.73, with forecasts ranging from $34 to $50 per share
- Based on the Aug. 5 closing price, the updated target implies approximately 15% potential upside
- Consensus rating remains at “Buy” across 13 covering analysts, with 12 Buys, 1 Holds and 0 Sells
Explore more price target data and ratings for Roivant Sciences Ltd. on the , and track all previous and future analyst recommendations for Roivant Sciences Ltd. in the dedicated News Flow.
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.